Endocrine Disrupting Chemicals in Consumer Products posted on Mar 20, 2018
This course qualifies for CME, CNE, CEU, CECH, and CPH provided by the Centers for Disease Control.
Endocrine Disrupting Chemicals in Consumer Products is a three-part series of interactive, self-paced eLearning modules. The goal of this series is to enhance the knowledge of physicians and other healthcare providers about endocrine disrupting chemicals (EDCs) including populations who may be vulnerable to exposure, identification of EDCs in consumer products, potential health effects of exposure, and exposure prevention strategies. By enhancing their knowledge, physicians and other healthcare providers can better assess patients who may be exposed to EDCs in consumer products. This series includes the following courses:
Endocrine Disrupting Chemicals in Consumer Products: Introduction
Endocrine Disrupting Chemicals in Consumer Products: Identification and Health Effects
Endocrine Disrupting Chemicals in Consumer Products: Prevention
Timur Durrani, MD, MPH
Medical Director, Health Services, Lawrence National Laboratory, Berkeley, CA
Dr. Durrani an Associate Clinical Professor of Medicine at the University of California San Francisco, where he holds appointments in the Department of Medicine, Division of Occupational and Environmental Medicine and Department of Family Medicine. Dr. Durrani earned his Medical Degree from the University of Arizona, where he also earned his Master of Public Health. He holds quadruple board certifications in Family Medicine, Preventive Medicine, Occupational Medicine and Medical Toxicology. His academic responsibilities include teaching medical and pharmacy students, as well as graduate medical trainees including Emergency Medicine, Occupational and Environmental Medicine residents, and Medical Toxicology Fellows. As a consultant for the Medical Toxicology Service, he provides clinical care for acutely poisoned patients at the San Francisco General Hospital, as well as outpatient Medical Toxicology consultations through the UCSF Occupational and Environmental Medicine Faculty Practice. He serves as Medical Toxicology consultant for the Agency for Toxic Substances and Disease Registry, Region 9, and the Environmental Protection Agency, Region 9. Dr. Durrani has publications in basic science and public health disciplines, and has presented abstracts in neurotoxicology.
Katelyn is currently a third-year medical student with prior experience with literature review and research previously in undergraduate studies and medical school
This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: U61TS000237 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: U61TS000238 from the Agency for Toxic Substances and Disease Registry (ATSDR).
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.
Endocrine Disruptors posted on Mar 20, 2018
This course is part of a series of short courses offered by the American College of Medical Toxicology on contemporary issues in environmental toxicology and environmental health developed by leading authorities in medical toxicology, under the direction of Drs. Michael Kosnett, Charles McKay and Paul Wax.
Andrew Stolbach, MD, FACMT
Assistant Professor of Emergency Medicine and Toxicology
John Hopkins University School of Medicine
Funding for this web-based learning module was made possible (in part) by the cooperative agreement award number 1U61TS000117-03 from the Agency for Toxic Substances and Disease Registry (ATSDR). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Created: January 2013